No results found for “”
No results found for filter “”
-
Statements & press releases 21.03.23
EU long-term competitiveness strategy has to apply to the EU Pharma legislation
We would like to call on the Commission to stand by its commitment to the Long-term competitiveness of the EU and deliver a comprehensive competitiveness...
Read Article -
Blog articles 21.03.23
Why pull incentives are key to catalysing private investment into antibiotics (Guest blog)
The advent of antibiotics was one of the fundamental drivers of the shift in health care that has dramatically increased life expectancy and improved quality...
Read Article -
Statements & press releases 20.03.23
New European legislation designed to protect patients is delaying clinical trials for thousands of people...
The number of clinical trials delayed is expected to run into the hundreds, affecting up to 42,200 patients over the next three years, according to a survey...
Read Article -
Statements & press releases 16.03.23
EBC & EFPIA launch RETHINKING Alzheimer’s disease White Paper
On the occasion of the Brain Awareness Week, the European Brain Council (EBC) and EFPIA launched the RETHINKING Alzheimer’s disease White Paper, calling...
Read Article -
Blog articles 16.03.23
A modernised EU Variation Framework for enhancing the life of European patients
Regulatory Road to Innovation
Read Article -
Blog articles 16.03.23
Cross-stakeholder action is key to ensuring continued patient access to improved treatments in oncology...
Endpoints that measure time to disease progression or tumour shrinkage may provide a better approach to assessing novel therapies in oncology.
Read Article -
Blog articles 16.03.23
An inclusive discussion to design an ideal PULL mechanism (Guest Blog)
A silent pandemic is around the corner: antimicrobial resistance. The problem? The innovation engine, meant to provide the means to fight it, has stalled....
Read Article -
Blog articles 15.03.23
EU Competitiveness: Mind the gap between rhetoric and reality
Now is the time to decide what kind of Europe we want to live in – a global hub for the research, development and manufacture of the latest vaccines and...
Read Article -
Blog articles 08.03.23
From COVID-19 Pandemic to War: Clinical Trial Industry Powers On Under Extreme Conditions (Guest Blog)...
Special Section: Clinical Research in Ukraine
Read Article -
Blog articles 08.03.23
International Women's Day 2023
Collectively we can all #EmbraceEquity
Read Article -
Blog articles 02.03.23
Dynamic Regulatory Assessment will support more efficient treatment development for patients: the time...
Regulatory Road to Innovation
Read Article -
Blog articles 01.03.23
This March we are moving together against Colorectal Cancer! #ECCAM2023
#ECCAM2023 is an opportunity to encourage those eligible for colorectal cancer screening to get screened: early detection reduces mortality and improves...
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 15.12.22
EFPIA survey among member companies on compliance with the EFPIA-PHRMA principles for responsible clinical...
EFPIA members continue to be committed to responsible clinical trial data sharing, for the benefit of patients and researchers
Read Article -
EFPIA News 13.12.22
IHI launches new funding round
The Innovative Health Initiative (IHI) has launched its third call for proposals, featuring topics covering rare diseases and mental health, and addressing...
Read Article -
EFPIA News 07.11.22
Europe’s share of global medicines R&D shrinks by a quarter in 20 years – as sector’s declining trends...
EFPIA is warning that the options being discussed by policy makers in the context of the EU Pharma Strategy fall well short of addressing concerns and...
Read Article -
EFPIA News 05.10.22
Pharmaceutical industry response to the war in Ukraine
Supporting people affected by the war
Read Article -
EFPIA News 16.06.22
European Multi-Stakeholder Sounding Board Meeting on “Innovation – The key to sustainable cancer care”...
Join the sounding board to discuss how high-quality care pathways and innovation can alleviate the pressure, improve sustainable patient access to high...
Read Article -
EFPIA News 24.05.22
RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!
Now is the time to rethink Alzheimer’s disease to improve Alzheimer’s disease care pathway and the lives of people living with it.
Read Article -
EFPIA News 02.05.22
Roberta Savli appointed as Executive Director of Public Affairs at EFPIA
Roberta will take on the new role with immediate effect.
Read Article -
EFPIA News 28.04.22
EFPIA Recommendations on a Connected Data System in Europe
A connected health data ecosystem has the potential to empower more effective and efficient research and development of new treatments and diagnostics....
Read Article -
EFPIA News 22.04.22
Implementing “Good Lay Summary Practice”
Final report of the GLSP Workshop held on the 14, 15 & 21 February 2022.
Read Article -
EFPIA News 11.04.22
New proposals from the research-based pharmaceutical industry should reduce inequalities in patient access...
Europe's pharmaceutical sector is stepping up measures to help deliver faster, more equitable access to medicines for millions of patients across the EU....
Read Article -
EFPIA News 06.04.22
Shortening the WAIT - Patient Access to Medicines in Europe
Disparities in the time it takes for patients to access new medicines in different EU Member States are increasing.
Read Article -
EFPIA News 27.01.22
Shifting the paradigm for ATMPs
Adapting reimbursement and value frameworks to improve patient access in Europe
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 21.03.23
EU long-term competitiveness strategy has to apply to the EU Pharma legislation
We would like to call on the Commission to stand by its commitment to the Long-term competitiveness of the EU and deliver a comprehensive competitiveness...
Read Article -
Statements & press releases 20.03.23
New European legislation designed to protect patients is delaying clinical trials for thousands of people...
The number of clinical trials delayed is expected to run into the hundreds, affecting up to 42,200 patients over the next three years, according to a survey...
Read Article -
Statements & press releases 16.03.23
EBC & EFPIA launch RETHINKING Alzheimer’s disease White Paper
On the occasion of the Brain Awareness Week, the European Brain Council (EBC) and EFPIA launched the RETHINKING Alzheimer’s disease White Paper, calling...
Read Article -
Statements & press releases 28.02.23
Because we can’t afford not to - Let’s make a joint health check for cardiovascular disease (CVD) and...
Join us in the European Parliament
Read Article -
Statements & press releases 17.02.23
“Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation”, The Lancet,...
Read Article -
Statements & press releases 10.02.23
EFPIA reaction to leak of the proposed pharmaceutical legislation
Whether it is naivety, blind optimism or a more conscious decision for Europe to rely on innovation from the US and Asia, there should be no doubt that...
Read Article -
Statements & press releases 09.02.23
Industry Statement on the earthquakes in Turkey and Syria
Industry will continue to work with partners and authorities across Europe to provide further support where possible.
Read Article -
Statements & press releases 06.02.23
EFPIA response to EU Commission proposal for revised EMA Fees regulation
EFPIA welcomes the opportunity to provide feedback on the EU Commission proposal for a revised EMA Fees regulation.
Read Article -
Statements & press releases 31.01.23
EFPIA update on the readiness for mandatory use of the Clinical Trials Regulation
A majority of EFPIA members have already submitted at least one clinical trial application through the Clinical Trials Information System (CTIS), the electronic...
Read Article -
Statements & press releases 30.01.23
EBC & EFPIA hold RETHINKING Alzheimer’s event ahead of policy paper launch
The European Brain Council (EBC), in collaboration with EFPIA, organised a digital event looking at the need to rethink the way we approach detection and...
Read Article -
Statements & press releases 25.01.23
Europe’s cancer community sets out best practice guide to sustainable, equitable and transformative patient...
Smart investments in cancer care are urgently needed to alleviate demands on healthcare systems and improve access to cancer care
Read Article -
Statements & press releases 25.01.23
EFPIA response to medicines shortages reports
EFPIA member companies are not reporting shortages as a result of the situation in China, and where necessary have increased supply
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 21.03.23
Why pull incentives are key to catalysing private investment into antibiotics (Guest blog)
The advent of antibiotics was one of the fundamental drivers of the shift in health care that has dramatically increased life expectancy and improved quality...
Read Article -
Blog articles 16.03.23
A modernised EU Variation Framework for enhancing the life of European patients
Regulatory Road to Innovation
Read Article -
Blog articles 16.03.23
Cross-stakeholder action is key to ensuring continued patient access to improved treatments in oncology...
Endpoints that measure time to disease progression or tumour shrinkage may provide a better approach to assessing novel therapies in oncology.
Read Article -
Blog articles 16.03.23
An inclusive discussion to design an ideal PULL mechanism (Guest Blog)
A silent pandemic is around the corner: antimicrobial resistance. The problem? The innovation engine, meant to provide the means to fight it, has stalled....
Read Article -
Blog articles 15.03.23
EU Competitiveness: Mind the gap between rhetoric and reality
Now is the time to decide what kind of Europe we want to live in – a global hub for the research, development and manufacture of the latest vaccines and...
Read Article -
Blog articles 08.03.23
From COVID-19 Pandemic to War: Clinical Trial Industry Powers On Under Extreme Conditions (Guest Blog)...
Special Section: Clinical Research in Ukraine
Read Article -
Blog articles 08.03.23
International Women's Day 2023
Collectively we can all #EmbraceEquity
Read Article -
Blog articles 02.03.23
Dynamic Regulatory Assessment will support more efficient treatment development for patients: the time...
Regulatory Road to Innovation
Read Article -
Blog articles 01.03.23
This March we are moving together against Colorectal Cancer! #ECCAM2023
#ECCAM2023 is an opportunity to encourage those eligible for colorectal cancer screening to get screened: early detection reduces mortality and improves...
Read Article -
Blog articles 28.02.23
How the Rare Disease Moonshot can unlock science for patients
For most rare diseases, there is not enough science to translate into innovative products. It’s time to change this together through public-private collaboration....
Read Article -
Blog articles 23.02.23
How Regulation Can Boost the EU Innovation?
Technology moves fast. An agile and streamlined innovation ecosystem would make Europe more competitive and bring breakthroughs to patients.
Read Article -
Blog articles 15.02.23
Pushing the boundaries of science to beat childhood cancers (Guest blog)
Earlier diagnosis, more new treatments and better data can help beat paediatric cancers
Read Article